The most recent trading session ended with Alkermes (ALKS) standing at $29.45, reflecting a +1.76% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 1.03%. Meanwhile, the Dow gained 0.34%, and the Nasdaq, a tech-heavy index, added 1.51%.The drugmaker's shares have seen an increase of 8.39% over the last month, surpassing the Medical sector's gain of 2.1% and the S&P 500's gain of 3.21%.Market participants will be closely following the financial results of Alkerme ...